Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Focus (American Psychiatric Publishing)
|
February 5, 2020
Antidepressant Prescribing in the Precision Medicine Era: a Prescriber's Primer on Pharmacogenetic Tools
Chad A Bousman, Malcolm Forbes, Mahesh Jayaram, et al.
Patient Preference and Adherence
|
December 6, 2022
Perceptions with Type 2 Diabetes Mellitus of the Value of Prescribed Medications Among Malaysian Adults: A Qualitative Study
Ming Chiang Lim, Ernieda Hatah, Kay Chee Lai, et al.
BMC Psychiatry
|
August 9, 2020
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
Alice Maier, Anita Dharan, Gina Oliver, et al.
The Journal of ECT
|
August 23, 2014
Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy
Chad A Bousman, Natalie Katalinic, Donel M Martin, et al.
Human Psychopharmacology
|
September 10, 2013
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
Chee Ng, Jerome Sarris, Ajeet Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study
Alejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.
Psychiatry Research
|
August 4, 2023
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD
Richard A Kanaan, Gina Oliver, Anita Dharan, et al.
Journal of Clinical Psychopharmacology
|
May 3, 2013
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
Jerome Sarris, Con Stough, Chad A Bousman, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 20, 2015
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial
Olivia May Dean, Michael Maes, Melanie Ashton, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
December 5, 2015
Art and mental health in Samoa
Brigid Ryan, Margaret Goding, Patricia Fenner, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Focus (American Psychiatric Publishing)
|
February 5, 2020
Antidepressant Prescribing in the Precision Medicine Era: a Prescriber's Primer on Pharmacogenetic Tools
Chad A Bousman, Malcolm Forbes, Mahesh Jayaram, et al.
Patient Preference and Adherence
|
December 6, 2022
Perceptions with Type 2 Diabetes Mellitus of the Value of Prescribed Medications Among Malaysian Adults: A Qualitative Study
Ming Chiang Lim, Ernieda Hatah, Kay Chee Lai, et al.
BMC Psychiatry
|
August 9, 2020
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol
Alice Maier, Anita Dharan, Gina Oliver, et al.
The Journal of ECT
|
August 23, 2014
Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy
Chad A Bousman, Natalie Katalinic, Donel M Martin, et al.
Human Psychopharmacology
|
September 10, 2013
Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression
Chee Ng, Jerome Sarris, Ajeet Singh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study
Alejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.
Psychiatry Research
|
August 4, 2023
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD
Richard A Kanaan, Gina Oliver, Anita Dharan, et al.
Journal of Clinical Psychopharmacology
|
May 3, 2013
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
Jerome Sarris, Con Stough, Chad A Bousman, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology
|
January 20, 2015
Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial
Olivia May Dean, Michael Maes, Melanie Ashton, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
December 5, 2015
Art and mental health in Samoa
Brigid Ryan, Margaret Goding, Patricia Fenner, et al.
Page
of 6